Applied Therapeutics, Inc. — Director's Dealing 2022

Mar 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-03-21

Reporting Person: Perfetti Riccardo (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-21	Common Stock	P	12548	$1.85	Acquired	108948	Direct
2022-03-22	Common Stock	P	21961	$1.98	Acquired	130909	Direct
2022-03-23	Common Stock	P	30000	$1.97	Acquired	160909	Direct

Footnotes

F1: These shares were purchased by Dr. Perfetti in multiple transactions.

F2: Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.8100 to $1.9200 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.9000 to $2.0900 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.8600 to $2.1000 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.